In the complex world of drug discovery, 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗶𝗻𝘁𝗿𝗶𝗰𝗮𝘁𝗲 𝗯𝗶𝗼𝗰𝗵𝗲𝗺𝗶𝗰𝗮𝗹 𝗰𝗵𝗮𝗻𝗴𝗲𝘀 𝗶𝗻 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝘀𝘁𝗮𝘁𝗲𝘀 is critical. 𝗨𝗻𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 is transforming our ability to 𝘂𝗻𝗰𝗼𝘃𝗲𝗿 𝗻𝗼𝘃𝗲𝗹 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀, 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗺𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝗺𝘀, 𝗮𝗻𝗱 𝗱𝗿𝘂𝗴 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗲𝘀—without bias or predefined targets. But how does it work? And why is it a game-changer for biotech and pharma? Our latest blog, entitled 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝘁𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗨𝗻𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗼𝗺𝗶𝗰𝘀 𝗶𝗻 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆, dives into: • How untargeted metabolomics accelerates drug discovery • Its impact on precision medicine and biomarker discovery • Why this approach is revolutionizing therapeutic innovation Read more and explore its potential- https://hubs.ly/Q03cGV2j0 #Metabolomics #Biomarkers #PrecisionMedicine
About us
Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients. Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing. We aspire to contribute data-driven disease understanding and early disease relevance in humans to bring the probability of success up. We select the right modality, which is then propelled forward on our platforms by our passionate people striving for the fastest and most effective ways towards patient impact. This is enabled by convergence of human ingenuity with data and AI. We also offer specific solutions, products, and CRO/CDMO-like services, always in support of the Biopharma R&D innovator. Our more than 4,000 scientists work closely with numerous partners concurrently, delivering fully integrated research and development portfolios or individual projects with the highest quality standards and efficiency, coupled with great science, passion, engagement, and communication.
- Website
-
http://www.evotec.com
External link for Evotec
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Hamburg
- Type
- Public Company
- Specialties
- CNS, Oncology, Pain, Neurosciences, Inflammation, Metabolic disease, Infection, Respiratory diseases, Drug-Discovery, CMC, IND enabling, and Drug Development
Locations
-
Primary
Get directions
Manfred Eigen Campus
Essener Bogen 7
Hamburg, 22419, DE
Employees at Evotec
Updates
-
Unlocking Quality by Design: Quality Risk Management What are the key principles of Quality Risk Management (QRM) in drug product development? In the fourth episode of our "Mastering Quality by Design" webinar series, Simone Tescari will provide an overview of QRM philosophy aligned with ICHQ9 guidelines. How can effective risk management enhance your development cycle? https://hubs.ly/Q03c4tM80 Discover critical insights from our experts and watch the full "Mastering Quality by Design" series on demand!
-
-
Evotec reposted this
How can deeper insights into the immunological synapse accelerate immunotherapy discovery? Join our upcoming webinar, Driving Immunotherapy Discovery Through Analyzing the Immunological Synapse, to explore how advanced imaging and single-cell technologies are transforming immunotherapy research. Key Discussion Points: • Cutting-edge imaging techniques for visualizing T-cell interactions • The role of single-cell analysis in biomarker discovery • How these insights are shaping next-generation immunotherapies Gain expert perspectives on the latest innovations in immunology and drug development. Register now- https://hubs.ly/Q03chqvs0 #ImmunoTherapy #Immunology #Biomarker #Webinar
-
-
𝗘𝘃𝗼𝘁𝗲𝗰 𝗣𝗮𝗻𝗢𝗺𝗶𝗰𝘀: 𝗠𝗲𝗲𝘁 𝗛𝗮𝗻𝗻𝗮𝗵 𝗘𝗹𝗶𝘀𝗮 𝗞𝗿𝗮𝘄𝗰𝘇𝘆𝗸 We are proudly presenting a new video series, ‘Meet Our Computational Biology Experts’! Join us on our journey to meet the talented team and learn more about PanOmics, Evotec’s multi-omics supported drug discovery! Hannah Elisa is a research scientist at computational biology department at Evotec, responsible for analysis and interpretation of genetic and genomics data. Watch this introduction from Hannah Elisa to learn: • Why genetic and genomics data are important in drug discovery • How Evotec assesses genetic evidence to predict the efficacy and safety of drug targets • What can you do to raise probability of success Stay tuned as we share more insights, highlighting the inspiring research and the amazing work behind the scenes delivering cures to patients! #beCUREious Explore more on our website – https://hubs.ly/Q03cV1tT0 #beCUREious #ResearchNeverStops #Employee #LifeSciences #DrugDiscovery #MedicinesThatMatter #DataAnalytics #Bioinformatics #ComputationalBiology # PanHunter #MultiOmics #PanOmics #Genomics #Genetics #TargetId
-
Join us on 9 April, for a webinar on leveraging locked nucleic acid chemistry to enhance oligonucleotide characterization. Discover advanced pharmacokinetic models and screening strategies that optimize ASO design straight from industry experts. Register now to elevate your oligonucleotide drug discovery approach. https://hubs.ly/Q03dsj-W0 #Oligonucleotides #Oligo #LNA #ASO #DrugDiscovery #ASOBasedDrugs #OligonucleotideTherapeutics
-
-
Exciting advancements in immuno-oncology! Read our recent article in Cancer Immunology, Immunotherapy journal to learn more about how the Evotec #immunology team collaborated with #Genentech teams and co-authored this article by bringing Immunological Synapse expertise to strengthen Genentech ICE characterization. The article is open access and available here- https://hubs.ly/Q03cGQwc0 #biologics #bispecificantibody #immunooncology
-
-
𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗖𝗲𝗹𝗹𝘂𝗹𝗮𝗿 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 & 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 High-quality cellular reagents are critical to streamlining drug discovery and biopharmaceutical development. Evotec’s Cellular Sciences offers: • Custom stable cell line development • Assay-ready frozen cells to reduce variability and hands-on time • High-purity membrane preparations for robust binding studies • Scalable monoclonal antibody expression Download the Cellular Sciences Factsheet to learn how our tailored solutions can accelerate your projects- https://hubs.ly/Q03cGLvs0 Want to discuss your needs directly? Contact our experts info@evotec.com #CellSciences #DrugDiscovery #Pharma #Biotech #BioReagents
-
Imagine there is a comprehensive tool that supports you to manage, explore, analyze and interpret biological data in the fastest, easiest, most visual and collaborative way. A tool well suited for experts of various scientific profiles. With PanHunter you decide whether you run a standardized analysis and interact with the data via the graphical user interface, or use your own custom scripts and the API. Contact us now to start analyzing your omics data with PanHunter- https://hubs.ly/Q03cHxQM0 #researchneverstops #medicinesthatmatter #drugdiscovery #panhunter #bioinformatics #omics #dataanalysis #datascience #transcriptomics #proteomics #singlecell #spatial
-
How can Design of Experiments (DoE) improve chemical reactions in API development? Join Francesco Tinazzi in our third episode as he discusses the advantages of using DoE over traditional methods. Are you maximizing the efficiency of your chemical development processes? https://hubs.ly/Q03c486r0 Watch the complete "Mastering Quality by Design" series, all episodes are on demand!
-
-
How can deeper insights into the immunological synapse accelerate immunotherapy discovery? Join our upcoming webinar, Driving Immunotherapy Discovery Through Analyzing the Immunological Synapse, to explore how advanced imaging and single-cell technologies are transforming immunotherapy research. Key Discussion Points: • Cutting-edge imaging techniques for visualizing T-cell interactions • The role of single-cell analysis in biomarker discovery • How these insights are shaping next-generation immunotherapies Gain expert perspectives on the latest innovations in immunology and drug development. Register now- https://hubs.ly/Q03chqvs0 #ImmunoTherapy #Immunology #Biomarker #Webinar
-